期刊文献+

喉鳞癌患者血清MMP-9及VEGF-C检测的临床意义

下载PDF
导出
摘要 目的:探讨喉鳞癌病人血清中基质金属蛋白酶-9(matrix metalloproteinases-9,MMP-9)和血管内皮生长因子-C(vascular endothelial growth factor-C,VEGF-C)的变化的意义。方法:选取经病理切片证实的喉鳞癌82例患者(恶性组)和良性喉部病变70例(良性组),各抽取患者静脉血3 mL检测MMP-9和VEGF-C,并与45例健康人血清作对照,探讨两者在喉鳞癌的变化及关系。结果:MMP-9含量良性组与恶性组比较、对照组与恶性组比较,均有统计学意义(均P<0.05),良性组与对照组比较无统计学意义(P>0.05);VEGF-C含量良性组和恶性组比较、对照组和恶性组比较,均有统计学意义(均P<0.05),良性组与对照组比较无统计学意义(P>0.05)。MMP-9含量与VEGF-C含量之间存在正相关(r=0.512,P<0.05)。结论:MMP-9及VEGF-C均在喉鳞癌患者中含量有较高的敏感性,两者与喉鳞癌的诊断、转移及预后有较密切的关系。有可能成为喉癌诊断治疗的生物学指标。
作者 王霞
出处 《山西职工医学院学报》 CAS 2012年第2期14-16,共3页 Journal of Shanxi Medical College for Continuing Education
  • 相关文献

参考文献5

  • 1葛明华,谷志远,徐晓红,王可敬,谭卓,梁忠.头颈部粘膜鳞状细胞癌患者血清血管内皮生长因子水平及意义[J].现代口腔医学杂志,2003,17(6):507-509. 被引量:1
  • 2Xie M, Sun Y, Li Y. Expression of M at rixMeta-I Loproteinases in Su- prag Lottic Carcinoma and It~ Clinical Implication for Estimating Lymph Node Metastases[ J ]. Laryngoscope, 2004, 114(12) :2243-2249.
  • 3Auerbach R,Lewis R,Shinners B,et al.Angiogenesis Assays:a Criti-caloverview[J].Clin Chem,2003,49(1):32-40.
  • 4Kim KJ,Winer J,Armanini M,et al.Inhibition of Vascular-Endothe-lial-Growth-Fact or Induced Angiogenesis Suppresses Tumor Growth inVivo[J].Nature(Lond),1993,362(6423):841-844.
  • 5Riedel F,Gotte K,Schwald J,et al.Expression of 92-kDa TypeⅣCollagenase Correlates with Angiogenic Markers and Poor Survival inHead and Neck Squamous Cell Carcinoma[J].Int J Oncol,2000,17:1099-1105.

二级参考文献8

  • 1Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial grow'th factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol, 1995,146 ( 5 ) : 1029 -1039.
  • 2Mineta H, Miura K, Ogino T, et al. Prognostic value of vascular endothelial growth factor (VEGF)in head and neck squarnous cell carcinorras. Br J Cancer,2000,83(6) :775 - 781.
  • 3Shintani S, Kiyota A, Mihara M, et al. hsaocoation of preoperative ratiation effect with tumor angoogenesis and vascular endithelial growth factor in oral squamous cell carcinom. Jpn J Cancer Res,2000,91 (10) : 1051 - 1057.
  • 4Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non - Hodgkin's lymphoma. Blood, 1997, 90(8) :3167 - 3172.
  • 5Bondestam J, Salven P, Jaaskela H, et al. Major surgery increases sertma levels of vascular endothelial growth factor only temporarily.Am J Surgery,2000,179( 1 ) :57 - 59.
  • 6Salven P, Ruotsalainen T, Mattson K, et al. High pre - treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small - cell lung cancer. Int J Cancer, 1998,79(2) : 144- 146.
  • 7Kim KJ, Winer J, Armanini M, et al. Inhibition of vascular -endothelial - growth - factor - induced angiogenesis suppresses tumout growth in vivo. Nature ( Lond ), 1993,362 ( 6423 ) : 841 -844.
  • 8Sato K, Tsuehiya N, Sasaki R, et al. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma. Jpn J Cancer Res, 1999,90(8) :874 - 879.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部